key: cord-0758258-yjrcyufx
authors: Clyne, Barbara; Walsh, Kieran A.; O'Murchu, Eamon; Sharp, Melissa K.; Comber, Laura; O’ Brien, Kirsty K; Smith, Susan M.; Harrington, Patricia; O'Neill, Michelle; Teljeur, Conor; Ryan, Máirín
title: Using Preprints in Evidence Synthesis: Commentary on experience during the COVID-19 pandemic
date: 2021-05-19
journal: J Clin Epidemiol
DOI: 10.1016/j.jclinepi.2021.05.010
sha: 7327d5dd955621ff2a3d4593a3c0252d39deca97
doc_id: 758258
cord_uid: yjrcyufx

nan

Key findings  Evidence syntheses are increasingly drawing on preprint servers as a source for emergent literature on COVID-19. Our research group, has conducted a large number of rapid reviews of a broad range of public health topics related to COVID-19. We outline several considerations when including preprints in rapid reviews and lessons learned from this process.

What this adds to what is known  Including preprints in rapid reviews has implications for the rapid review process and review teams should have clear protocol regarding the selection and coverage of bibliographic databases, indication within reviews where an included study is a preprint and prespecifying any sensitivity analysis (quantitative or narrative) to assess the impact of inclusion of preprints on the overall results and conclusions.

 Specific challenges encountered in including preprints in rapid reviews such as those related to matching preprints to subsequent peer review publications and dealing with changes between preprints and peer review publications are presented using three exemplar review, and suggestions for study authors and review teams are provided.

 We suggest that preprint study authors include a statement in the final peer-reviewed version of the manuscript with the citation of the preprint version.

Introduction SARS-CoV-2, the virus that causes COVID-19, has rapidly spread, causing millions of cases and deaths globally. Controlling the COVID-19 pandemic requires swift decision making based on initially sparse, and rapidly emerging evidence. There has been a proliferation of scientific literature in basic science, clinical medicine and public health disseminated through traditional peer review and increasingly, due to the urgent need for information, shared on preprint servers. (1, 2) Preprint servers are repositories of preliminary or advanced manuscripts that have not undergone formal peer review. Typically, preprint manuscripts precede those submitted to peer-reviewed journals, but they can also be published simultaneously. (3) Editorial staff of preprint servers perform screening checks related to article scope, plagiarism and compliance with legal or ethical standards. (4, 5) The majority of preprint servers provide a DOI for each manuscript. (4) Manuscripts will remain on the servers and while up to a third will later be published in peer-reviewed journals (resulting in multiple versions of the same study (6) ), some may never be submitted for peer review or be accepted. (6) (7) (8) (9) The advantages of preprints include early and rapid dissemination, opportunities for informal commenting, potential decreased publication bias and greater recognition and visibility of work, particularly for early-career researchers. (10) (11) (12) Evidence also suggests that peer-reviewed articles with a co-existing preprint are associated with more attention and citations than those without a preprint. (8, 13) The number of papers published on preprint servers has increased steadily since the beginning of the COVID-19 pandemic. In the early stages of the pandemic (up to April 2020) the majority of preprint articles were published by authors from China and were modelling studies. (1, 14) When compared to non COVID-19 related preprints, COVID-19 related preprints are shorter, contain fewer references and have more variability in authorship team size, with single-authorship more common. (15) While the rapid sharing of research findings may be invaluable, concerns have been raised about circulating preprint versions of articles before they have been through peer review quality assurance processes, particularly in disciplines like medicine, where flawed research could lead to risks to patient safety. (16) While preprints may potentially decrease publication bias, they may also increase it through publication of small positive studies, they may influence media discourse, and a lack of awareness of the difference between preprints and published articles may lead to inaccurate preprints being shared as authoritative. (17, 18) Examples of this during the COVID-19 pandemic include two small linked preprints studies examining the association between smoking and COVID-19 gaining significant media attention, leading to claims that smoking is protective. (19) Another preprint suggesting similarities between COVID-19 and HIV caused significant online commentary and was subsequently withdrawn. (20) Despite their potential drawbacks, preprint servers are playing an increasing role in informing decision-making during the current pandemic due to the need for timely evidence. (21) Evidence syntheses are increasingly drawing on preprint servers as a source for emergent literature on COVID-19. (21) Given the limitations of preprints, and concerns about the potential for harm in disciplines such as medicine, it is important to examine the feasibility of including preprints in rapid evidence reviews and explore their impact on review conclusions. (22) Our research group, has conducted a series of rapid reviews of a broad range of public health topics related to COVID-19. These reviews arose directly from questions posed by policy makers and clinicians supporting Ireland's National Public Health Emergency Team (NPHET). In keeping with rapid review methodology guidance, (22, 23) standardised protocols were used. (24) Findings from these reviews have informed the national response to the COVID-19 pandemic in Ireland (25) and may also inform international health policy as well as clinical and public health guidance. In this article, we outline the impact of the inclusion of preprint manuscripts using three exemplar rapid reviews. (26) (27) (28) We specifically describe issues we have encountered when including preprints in our rapid reviews, along with lessons learned, and suggestions for preprint study authors and review teams.

Impact of including preprints on the rapid reviews produced Exemplar reviews

To highlight the issues we encountered in including preprints in rapid reviews of SARS-CoV-2 topics, we selected three exemplar peer reviewed rapid reviews produced by our team that varied in scope and where ≥ 10% of included studies were preprints produced by our team. The reviews focused on viral load, (27) immunity, (26) and transmission (28) (Table 1) . (27) Objectives: summarise the evidence on the detection pattern and viral load of SARS-CoV-2 over the course of an infection

Preprints: 17/113 (15%)

Conclusions: There is a relatively consistent trajectory of SARS-CoV-2 viral load over the course of COVID-19 from respiratory tract samples, however the duration of infectivity remains uncertain.

Removal of the 17 preprint studies would not change the overall findings of the review.

Two pre-prints that compared viral load and culture positivity between children and adults were the only studies that specifically examined the differences at that time. However, the findings were broadly consistent with what was implied from the included journal articles.

Objectives: summarise the evidence on the immune response and reinfection rate following SARS-CoV-2 infection.

Preprints: 21/102 (20.6%)

Conclusions: Limited early data suggest that most patients seroconvert for SARS-CoV-2-specific IgG within 2 weeks. While the long-term duration of antibody responses is unknown, evidence from SARS-CoV studies suggest SARS-CoV-specific IgG is sustained for 1-2 years and declines thereafter.

Yes. Preprints provided the most recent data on SARS-CoV-2 and even SARS-CoV. Our findings that anti-SARS-CoV-2 antibodies can be detected beyond 60 days post-symptom onset comes from data exclusively derived from preprints. Additionally, IgG seropositivity follow-up beyond 10 years in SARS-CoV studies was also limited to one preprint study. This study detected IgG at 12 years.

Preprints provided the longest follow-up and therefore contributed greatly to the maximum duration of detection of antibody responses. However, the findings relating to reinfection and seroconversion did not differ between preprint and journal articles.

Objectives: rapid review of studies on the transmission of SARS-CoV-2 by children.

Removal of the 7 preprint studies would not change the overall findings of the review.

All 3 modelling studies were preprints. The findings of these studies were consistent with the overall findings, but they were the only Children (28) Included studies: papers to use this method.

Abbreviations: IgG -Immunoglobulin G;

Preprints are published on preprint servers such as medRxiv and Research Square, with over 40 such servers having a biomedical or medical scope. (4) Initially, we searched individual preprint servers to locate COVID-19 relevant articles for inclusion in our rapid reviews (including the exemplar reviews, Inclusion of databases such as these in a search strategy simplifies the mechanisms of identification of preprints and facilitates greater efficiency. However, it is important to be cognisant that each database has different policies and coverage of preprint servers.

Overall, across the three exemplar rapid reviews (Table 1) , 243 studies were included, of which 45 (18.5%) were preprints at the time of writing of the review. (26) (27) (28) The majority of included studies were observational designs, with case series accounting for 68% of included studies. When looked at by publication type, included studies were broadly similar, case series accounted for 60% of preprints and 70% of journal articles (Figure 1 ). Modelling studies were less frequent overall, but consistent with trends of early COVID-19 publications, occurred more in the preprint group (9%) than the journal article group (0.5%) ( Figure 1 ). (14) It is important to distinguish between preprints and journal articles within a review, given the potential concerns about preprint quality. To help encourage transparency, we would suggest that researchers undertaking rapid reviews clearly indicate in the data extraction, written results and tables of included studies, where an included study is a preprint.

As preprints are not formally peer reviewed, concerns regarding quality persist. Across our three rapid reviews, (26) (27) (28) the majority of included studies were case reports and case series ( Figure 1 ). No gold standard methodological quality appraisal tool for such studies exist, and until the recent publication of the GRADE Guidelines on the certainty of modelled evidence, there has also been a lack of guidance on appraising modelling studies. (29) To allow for rapid and consistent methodological quality appraisal across these case reports and case series, we adapted our own tool, based on existing guidance at the time (March 2020) and used well established tools for other designs (e.g.

ROBINS-I tool for nonrandomised studies of interventions). (24) Using the tool we adapted, there was very little difference observed in the methodological quality between journal articles and included preprints (Figure 2 ), although no significance testing was conducted. Areas of poor methodological quality such as unclear criteria for case selection, non-consecutive selection of case series participants, and lack of demographic characteristics were similar across preprint and journal articles. Comparing articles published in bioRxiv and in PubMed-indexed journals in 2016, Carneiro et al. (30) reported that peer review had a statistically significant, but small impact on improving quality of reporting, suggesting that the quality of reporting in preprints did not differ greatly from their later peer-reviewed versions. In the context of COVID-19, the similarity in methodological quality between journal articles and the included preprints in our reviews (26) (27) (28) quality than with peer-review efficiency. (1) We therefore found no evidence to suggest that COVID-19 preprints should be considered less methodologically valid than COVID-19 peer-reviewed studies as both have limitations.

In terms of the presentation and overall quality of the manuscripts we found that included preprints tended to have grammatical and numerical errors (for example, differences in the main text and figures) which could lead to errors in interpretation. Image quality was also often poor and supplementary materials were often poorly described and labelled, or omitted, leading to difficulty interpreting information. Preprint servers offer authors the opportunity to amend errors and post new versions of a preprint. The majority of COVID-19 preprints have been found to have a single version, with some preprints existing beyond two versions. (6, 15) A single DOI may be retained for all versions. (4) No standard for a new version requirement was identified, thus new versions may cover varying levels of change and substantial changes between preprint versions have been identified. (6) We encountered cases where changes between versions were substantial, in one case with the addition of new participants (from 9 in version 1 to 76 in version 2 (32) ). In order to increase transparency and openness, we would suggest that preprint authors include a version control log within their manuscript, highlighting whether the changes are more substantial than simply amending grammatical errors.

Across the three included reviews, (26) (27) (28) meta-analysis was not feasible and narrative syntheses were conducted. As no meta-analyses were conducted, we cannot perform a quantitative sensitivity analysis around the impact of inclusion of preprints on the overall results. However, we were able to examine the consistency of the findings across reviews. In two of the reviews, the findings of included studies were largely consistent across the body of evidence and the removal of preprints would not have altered the overall review findings (Table 1) . (27, 28) In the review on immune responses, a rapidly evolving field, the removal of the preprints would have changed the overall findings of the review. (26) For this review, preprints provided the longest follow-up data and therefore contributed greatly to the maximum duration of detection of antibody responses; exclusion of these papers would have changed the overall conclusions regarding this duration. The other two reviews (27, 28) also included findings that were unique to included preprints, but these findings would not have changed the overall conclusions. For the viral load paper, two preprints compared viral load and culture positivity between children and adults and at the time of publication, these were the only papers that specifically examined differences between these groups. However, the findings were broadly consistent with what was implied from the other included journal articles. (27) The transmission in children review included three modelling studies estimating age-specific transmissibility of SARS-CoV-2, all of which were preprints. The findings of these studies were consistent with the overall findings of the review, however, they were the only papers to use this methodological approach. We suggest that authors conduct a sensitivity analysis (quantitatively or narratively) around the impact of inclusion of preprints on the overall results and conclusions.

Matching preprints to subsequent peer review publications

One of the main challenges of including preprints in our rapid reviews related to the subsequent identification of preprints that had undergone peer review and were published. Ordinarily, once a preprint has been accepted for publication in a peer-reviewed journal, the preprint server updates the entry with the final peer-reviewed citation and DOI, largely from title-based matching. (7) However, we have noted significant delays in preprint platforms being updated. For example, an included preprint posted March 19, 2020, (33) was published in a peer review journal May 1, 2020 (34) but as of December 4, 2020, the preprint server had not been updated (likely due to the change in title). To overcome this, our process is to manually search bibliographic databases to determine if a preprint has been subsequently peer-reviewed and published. Databases such as Europe PMC have implemented links between the preprint and published version of the same piece of work however, this process is time consuming, depending on the number of included preprints and complicated by the fact that, in some cases, the study title or the list of authors may have changed. A larger issue of matching preprints to subsequent peer review publications occurs where sections of a preprint article are included in a peer review paper, however, the two articles are substantially different. (35, 36) Without contacting the authors, there is no clear way to determine if the two similar papers are actually the preprint and final peer-reviewed version. We suggest that researchers undertaking rapid reviews who are including preprints, have a clear policy around whether they will or will not check peer review status of included preprints, and at what point in the review process this would occur. In order to increase transparency, we would also suggest that study authors include a statement in the final peer-reviewed version of the manuscript with the citation of the preprint version.

As preprint articles have not undergone peer review, it is possible that there will be substantial changes to the final peer-reviewed version. (6) Where no peer-reviewed version of an included preprint were identified, we clearly stated within the review which articles were preprints at the time of writing. Where we identified a peer-reviewed version of an included preprint subsequent to our search, we reviewed that version for any changes to data and interpretation. In the viral load review, we identified an increase in included study participants from 1,043 (33) in the preprint to 2,761 (34) in the peer-reviewed version. In the transmission in children review, we identified a large increase in included study participants from 288 (37) in the preprint to 42,618 (38) in the peer-reviewed version. Despite the significant increase in participants and changes to data, the overall conclusions remained similar in both cases. The process of cross-checking between the data extraction performed using the preprint and to the subsequent peer-reviewed manuscript is time consuming, but necessary as even subtle changes could lead to changes in the overall conclusions of the study and the evidence base of a rapid review. As such, we suggest that teams including preprints in their reviews, factor in adequate time and resources in their protocols for any necessary review updates, particularly for data extraction tables, arising from differences between included preprints and subsequently identified peer-reviewed versions. Alternatively, if review teams do not plan to crosscheck for published peer-reviewed versions, they should explicitly state this. Furthermore, we suggest that authors include a statement in the final peer-reviewed version of any substantial changes to the data or interpretation from the preprint version.

Suggestions for study authors and review teams from our experience to date are summarised in Table 2 . 

For rapid review teams:

 We found no evidence to suggest that COVID-19 preprints should be considered less methodologically valid than COVID-19 peer-reviewed studies.

 Preprint manuscripts may have grammatical and numerical errors and rapid review teams should have a clear protocol in place for dealing with errors such as contradictory results between tables and text.

 COVID-19 preprints, while a work in progress, should be double checked by the author team for inconsistencies in the reporting of data between tables/figures and text prior to depositing on a preprint server.

 Authors should include a version control log within the manuscript, highlighting changes between versions.

 Authors should use an appropriate standardised reporting checklist.

For rapid review teams:

 Rapid review teams should conduct a sensitivity analysis (quantitatively or narratively) to assess the impact of inclusion of preprints on the overall results and conclusions.

For rapid review teams:

 Rapid review teams should have a clear policy around whether they will or will not check peer review status of preprints included in a rapid review, and at what point in the review process this would occur.

 We suggest that study authors include a statement in the final peer-reviewed version of the manuscript with the citation of the preprint version.

For rapid review teams:

 Rapid review teams should factor in adequate time and resources in their protocols for any necessary review updates arising from differences between preprints and peer-reviewed manuscripts.

 If review teams do not plan to cross-check for published peerreviewed versions, they should explicitly state this.

 Authors should include a statement in the final peer-reviewed version of any substantial changes to the data or interpretation from the preprint version.

Managing the COVID-19 pandemic requires decision making based on the best available evidence, and preprints have formed a substantial part of the available evidence. Evidence from preprints must be used appropriately, recognising the initial intent of preprints as a mechanism to share preliminary or advanced manuscripts prior to peer review. We specifically outlined issues we encountered relating to including COVID-19 preprints in our rapid review process, along with lessons learned and suggestions for preprint study authors and review teams. We found that the quality of reporting in COVID-19 related preprints did not greatly differ from COVID-19 peer-reviewed studies and while the body of evidence was largely consistent across study type, some review findings were unique to the included preprints. Exclusion of preprints would have changed the conclusions for one of the three exemplar reviews. The value of including preprints with faster access to emerging evidence must be offset against their limitations, and the time and resources required to appraise, conduct sensitivity analysis and monitor changes from preprint status to peer-reviewed publication. 

Preliminary analysis of COVID-19 academic information patterns: a call for open science in the times of closed borders

Characteristics of academic publications, preprints, and registered clinical trials on the COVID-19 pandemic

Rise of the Rxivs: How Preprint Servers are Changing the Publishing Process. Medical reference services quarterly

Systematic examination of preprint platforms for use in the medical and biomedical sciences setting

Preprint Servers' Policies, Submission Requirements, and Transparency in Reporting and Research Integrity Recommendations

Changes in evidence for studies assessing interventions for COVID-19 reported in preprints: meta-research study

Tracking the popularity and outcomes of all bioRxiv preprints. eLife

Altmetric Scores, Citations, and Publication of Studies Posted as Preprints

Trends and analysis of five years of preprints

Preprints and Scholarly Communication: Adoption, Practices, Drivers and Barriers

On the value of preprints: An early career researcher perspective

Releasing a preprint is associated with more attention and citations for the peer-reviewed article. eLife

Research methodology and characteristics of journal articles with original data, preprint articles and registered clinical trial protocols about COVID-19

Preprinting the COVID-19 pandemic

The impact of preprint on media reporting of science

Early in the epidemic: impact of preprints on global discourse about COVID-19 transmissibility. The Lancet Global Health

The perils of preprints

How swamped preprint servers are blocking bad coronavirus research

Preprint manuscripts and servers in the era of coronavirus disease 2019

Rapid review methods more challenging during COVID-19: commentary with a focus on 8 knowledge synthesis steps

Interim Guidance from the Cochrane Rapid Reviews Methods Group

Protocol for evidence synthesis support -COVID-19

HIQA publishes COVID-19 evidence summaries to support work of the National Public Health Emergency Team

Immune response following infection with SARS-CoV-2 and other coronaviruses: A rapid review

SARS-CoV-2 detection, viral load and infectivity over the course of an infection

Transmission of SARS-CoV-2 by children: A Rapid Review

GRADE guidelines 30: the GRADE approach to assessing the certainty of modeled evidence-An overview in the context of health decision-making

Comparing quality of reporting between preprints and peer-reviewed articles in the biomedical literature

Poor quality research and clinical practice during COVID-19

Comparison of SARS-CoV-2 detection in nasopharyngeal swab and saliva

High transmissibility of COVID-19 near symptom onset

Contact Tracing Assessment of COVID-19 Transmission Dynamics in Taiwan and Risk at Different Exposure Periods Before and After Symptom Onset

Household transmissions of SARS-CoV-2 in the time of unprecedented travel lockdown in China

Reconstruction of Transmission Pairs for Novel Coronavirus Disease 2019 (COVID-19) in Mainland China: Estimation of Superspreading Events, Serial Interval, and Hazard of Infection

Epidemiology and transmission dynamics of COVID-19 in two Indian states

Epidemiology and transmission dynamics of COVID-19 in two Indian states

Writing -review & editing. Kieran A. Walsh: Conceptualization, Formal analysis, Resources, Data curation, Writing -review & editing. Eamon O'Murchu: Conceptualization, Formal analysis, Resources, Data curation, Writing -review & editing. Melissa K. Sharp: Formal analysis, Resources, Data curation, Visualization, Writing -review & editing

Resources, Writing -review & editing. Conor Teljeur: Conceptualization, Writingreview & editing. Máirín Ryan: Resources, Writing -review & editing

The authors would like to acknowledge the support of the Health Technology Assessment and Health Information and Standards Directorates at HIQA.